Calibre Scientific Expands Assisted Reproductive Technologies Portfolio With Strategic Acquisitions of Scopescreen and Microm UK Limited
LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisitions of Microm UK Limited and Scopescreen, LLC (dba Bioscreen) (“Scopescreen”), further solidifying its commitment to reproductive health and testing.
Microm, a UK-based provider of Assisted Reproductive Technology (“ART”), provides consumables and equipment involved in human and veterinary fertility and reproduction toxicology. Their innovative products and solutions have empowered researchers and clinicians throughout the British Isles, enabling breakthroughs in fertility treatments and genetic advancements.
Leslie Stump and Karen Collins, Directors of Microm UK Limited said:
“Microm UK Limited has built a stellar reputation with both customers and suppliers throughout the decades. We are excited about the growth that Microm UK Limited will experience in the years ahead as part of Calibre Scientific. We are confident that Calibre Scientific’s global resources will guarantee that both our customers and suppliers will continue to enjoy exceptional service from Microm into the future.”
For more information on Calibre Scientific, please visit our website.
Alternatively, please contact our press office.
Join the conversation